Effect of cAMP and cGMP on endothelin-stimulated tyrosine phosphorylation in rabbit platelets

Biochem Biophys Res Commun. 1995 Oct 4;215(1):219-26. doi: 10.1006/bbrc.1995.2456.

Abstract

Activation of platelets by different agents results in the increased tyrosine phosphorylation of several substrate proteins. Thus, the effect of endothelin-1 on the stimulation of tyrosine phosphorylation in rabbit platelets can be inhibited by preincubation with forskolin, which increase the cAMP level. However, incubations of platelets with 8-Bromo-cGMP showed lower inhibitory effect. Forskolin produced a dose-dependent inhibition on three different protein substrates, with an IC50 of approximately 12.8, 4.0 and 8.0 microM in the three molecular mass ranges of 50, 60 and 100-200 kDa, respectively. These results show that the endothelin-stimulated tyrosine phosphorylation in rabbit platelets can be regulated by a novel pathway of platelet signal transduction in which the cAMP level could be more relevantly involved than cGMP in some molecular mass ranges of tyrosine phosphorylated proteins.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Platelets / drug effects
  • Blood Platelets / metabolism*
  • Colforsin / administration & dosage
  • Colforsin / pharmacology
  • Cyclic AMP / pharmacology*
  • Cyclic GMP / administration & dosage
  • Cyclic GMP / analogs & derivatives
  • Cyclic GMP / pharmacology*
  • Dose-Response Relationship, Drug
  • Endothelins / pharmacology*
  • Molecular Weight
  • Phosphorylation
  • Phosphotyrosine / blood*
  • Rabbits
  • Signal Transduction

Substances

  • Endothelins
  • Colforsin
  • Phosphotyrosine
  • 8-bromocyclic GMP
  • Cyclic AMP
  • Cyclic GMP